As a trained economist who runs an E-pharmacy, the National Pharmaceutical Pricing Authority (NPPA) of India is an example of how government institutions can legitimize the worst tendencies of the free market. In this blog, I’ll establish a few key points: If you are interested in public-policy and pharmaceuticals, then this blog is for you. […]
Despite being called goddesses, women face systemic neglect in medicine. From overlooked side effects to underrepresentation in clinical trials, this blog exposes the hidden gender bias in healthcare and why it’s time women speak up and demand better.
Narrow therapeutic index (NTI) drugs walk a fine line — just like adding the perfect amount of spice to your favorite dish. A little too much, and the result can be harmful; too little, and it might not work at all. Medications like digoxin and warfarin require exact dosing and careful monitoring because even small changes can lead to serious side effects. In this blog, we break down what NTI drugs are, why they need special care, and how thoughtful practices – from regular check-ups to reliable sources like SayaCare – can make all the difference in using these powerful medicines safely.
Imagine choosing between two cups of chai – one from a trusted brand like Chaayos, and another from a local vendor offering the same taste at half the price. Tempting, right? But also risky? That’s exactly the kind of decision patients and doctors face with generic medicines in India. In this blog, I spoke to five doctors – from both government and private hospitals – and even had a quirky chat with a local quack (yes, our very own Bengali Babu) to uncover the real story behind branded vs. generic prescriptions. Plus, a look at how SayaCare is flipping the script on medicine access and trust.
With the patent period off for Empagliflozin, generic versions are expected, likely leading to increased access and lower prices.
Life-saving drugs pass through multiple hands-suppliers, manufacturers, distributors, retailers-each adding their cut. The price shoots up, but that’s not the worst part. Every extra layer in this chain increases the risk of fake or expired medicines slipping through.
With 20% of Indian medicines suspected to be counterfeit, the government mandated QR codes for 300 brands in 2022. But can they be easily bypassed?
Ever wondered why private hospital doctors prescribe expensive branded medicines instead of generics? Discover how medical representatives drive up your medicine costs in this blog.
Fake and spurious medicines are rapidly increasing in India, arising health concerns. Now the question is – should you trust the medicines you are buying?
Can Indian medicines really cure you? How much of Indian medicines are bad?